Denis Nikolov: A Call for Routine UACR Assessment in High-Risk Cardiovascular Patients
Denis Nikolov, Interventional Cardiologist shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Biomedical Journal of Scientific and Technical Research (BJSTR), adding:
”I’m pleased to share our newly published mini-review:
‘Should Cardiologists Routinely Measure the Urinary Albumin-to-Creatinine Ratio? A Mini Review’
In everyday cardiology practice, renal assessment is still often limited to serum creatinine and eGFR. However, preserved eGFR does not necessarily mean the absence of kidney damage.
Urinary albumin-to-creatinine ratio (UACR) provides complementary information and may help us:
- detect CKD despite preserved eGFR
- improve cardio-renal risk stratification
- identify high-risk patients earlier
- support timely initiation or optimization of evidence-based cardio-renal therapies
Our conclusion is straightforward: UACR should be strongly considered as part of routine assessment in cardiovascular patients at increased cardio-renal-metabolic risk, particularly those with heart failure, type 2 diabetes, arterial hypertension, or established atherosclerotic cardiovascular disease.
Proud to have worked on this together with Hristo Stoev and Petar Iliev.”
Title: Should Cardiologists Routinely Measure the Urinary Albumin-to-Creatinine Ratio? A Mini Review
Authors: Denis Nikolov, Hristo Stoev, Petar Iliev
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 12, 2026, 17:39Annie Bauzon: Differentiating Direct and Indirect Coombs Tests in Hematology
-
Oct 12, 2026, 17:15Cedric Hermans: Identifying and Diagnosing Hemophilia Carriers and Affected Females
-
Oct 12, 2026, 17:01Bianca Rocca: Evaluating Factor XI Inhibition Lessons from LIBREXIA-ACS
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026